Search
SOLACI Congress
HomeLesion typeBifurcations

Bifurcations

View Category

Bifurcations

Stent Optimal Minimal Area and Stent Underexpansion Impact in 2-Stent Left Main Treatment

The upfront 2-stent strategy for left main bifurcation treatment presents a technical challenge and has been associated...
Dr. Andrés Rodríguez -
Learn More
Bifurcations

Proximal Optimization Technique in Unprotected LMCA

Proximal optimization technique (POT) has been recommended as a standard strategy in bifurcation lesions because it facilitates...
solaci -
Learn More
Bifurcations

Long-term Results of Coronary Bifurcation Lesion Treatment in Diabetic Patients

The effects of diabetes on patients with coronary artery disease are well-known, and their outcomes after angioplasty...
solaci -
Learn More
Bifurcations

Treatment and Gender-Based Outcomes for Coronary Bifurcation Stent Placement: Report from the e-ULTIMASTER Registry

Approximately 20% of all percutaneous coronary interventions (PCI) are performed on bifurcation lesions, which continue to pose...
solaci -
Learn More
Bifurcations

BIFURCAT Registry: 1 or 2 Stents? Treatment of Side Branch (Medina 0.0.1) Lesions According to Real-World Data

Coronary bifurcation lesions have been a subject to debate, with different approaches by various medical teams. These...
solaci -
Learn More
Bifurcations

BIFURCAT Registry: Long Term Diabetes Impact on Bifurcations PCI Outcomes

The impact of diabetes in patients with coronary artery disease (CAD) are well known, and after percutaneous...
solaci -
Learn More
Bifurcations

ESC 2023 | OCTOBER TRIAL: Should We Begin to Consider OCT for Bifurcation Lesions?

The OCTOBER Study randomized 1201 patients with bifurcation lesions in a 1:1 ratio to undergo percutaneous transluminal...
solaci -
Learn More
Bifurcations

Provisional Stenting vs. Culotte: 5-Year Results of EBC TWO

The optimal treatment of true bifurcation lesions not affecting the left main coronary artery is widely debated....
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Sievers Type 1 Bicuspid Valves: Which to Use?

Dr. Carlos Fava - 0
One of the current challenges in TAVR is bicuspid aortic valves (BAV), because of their anatomical complexity, calcification, raphe presence, aortic dilation and associated...

AHA 2024 | VANISH2 Trial

Dr. Omar Tupayachi - 0
Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

Dr. Omar Tupayachi - 0
It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy